Skeletal aspects of Gaucher disease: a review

被引:175
作者
Wenstrup, RJ
Roca-Espiau, M
Weinreb, NJ
Bembi, B
机构
[1] Childrens Hosp Res Fdn, Div & Program Human Genet, Cincinnati, OH 45229 USA
[2] Hosp Miguel Servet, Dept Radiol, Musculoskeletal MRI Sect, Zaragoza, Spain
[3] Univ Gaucher Res Fdn Inc, Univ Gaucher Treatment Ctr, Tamarac, FL USA
[4] Burlo Garofolo Inst, Trieste, Italy
关键词
D O I
10.1259/bjr.75.suppl_1.750002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In Gaucher disease. a genetic deficiency in the activity of the lysosomal enzyme beta-glucocerebrosidase (acid beta-glucosidase) causes monocytes and macrophages to store excessive amounts of glucocerebroside in lysosomes. The resulting distended cells are called Gaucher cells. and the pathology associated with this condition stems from the accumulation of Gaucher cells in organ systems. The skeletal manifestations are probably the most disabling aspect of the disease. Patients commonly experience bone pain, some suffer bone crises. and up to 20%, have impaired mobility. Radiological findings include Erlenmeyer flask deformity, Osteopenia. osteosclerosis. osteonecrosis. fractures and bone marrow infiltration. Findings from the Gaucher Registry show that nearly all patients with Gaucher disease have radiological evidence of skeletal involvement, and the majority have a history of serious skeletal complications, Skeletal involvement follows three basic processes: focal disease (irreversible lesions such as osteonecrosis and osteosclerosis), local disease (reversible abnormalities adjacent to heavily involved marrow such is cortical thinning and long bone deformity) and generalized osteopenia. Infarctions are involved in sonic of the skeletal manifestations, but the mechanisms causing high rates of bone turnover and failure of remodelling are not known. The availability of a beta-glueocerebrosidase-deficient mouse model of Gaucher disease with long-term survival should help elucidate the skeletal Pathology in Gaucher disease and may ultimately lead to improved management of skeletal complications.
引用
收藏
页码:A2 / A12
页数:11
相关论文
共 45 条
[1]  
Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19
[2]  
Barak V, 1999, EUR CYTOKINE NETW, V10, P205
[3]   MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA [J].
BATAILLE, R ;
CHAPPARD, D ;
KLEIN, B .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :285-295
[4]   OSTEOMYELITIS IN GAUCHER DISEASE [J].
BELL, RS ;
MANKIN, HJ ;
DOPPELT, SH .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1986, 68A (09) :1380-1388
[5]   ENZYME REPLACEMENT TREATMENT IN TYPE-1 AND TYPE-3 GAUCHERS-DISEASE [J].
BEMBI, B ;
ZANATTA, M ;
CARROZZI, M ;
BARALLE, F ;
GORNATI, R ;
BERRA, B ;
AGOSTI, E .
LANCET, 1994, 344 (8938) :1679-1682
[6]   GAUCHER DISEASE AS A PARADIGM OF CURRENT ISSUES REGARDING SINGLE-GENE MUTATIONS OF HUMANS [J].
BEUTLER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5384-5390
[7]  
Beutler E., 1995, METABOLIC MOL BASES, P2641
[8]   SKELETAL SCINTIGRAPHY OF PSEUDOOSTEOMYELITIS IN GAUCHERS-DISEASE 2 CASE-REPORTS AND A REVIEW OF THE LITERATURE [J].
BILCHIK, TR ;
HEYMAN, S .
CLINICAL NUCLEAR MEDICINE, 1992, 17 (04) :279-282
[9]   THE ROLE OF NEUROGENETICS IN GAUCHER DISEASE [J].
BRADY, RO ;
BARTON, NW ;
GRABOWSKI, GA .
ARCHIVES OF NEUROLOGY, 1993, 50 (11) :1212-1224
[10]   METABOLISM OF GLUCOCEREBROSIDES .2. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHERS DISEASE [J].
BRADY, RO ;
KANFER, JN ;
SHAPIRO, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 18 (02) :221-&